Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: PSIOXUS THERAPEUTICS LIMITED
Awarding agency: Department of Defense / Defense Contract Management Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2012-09-04 to 2015-09-03
Current total value of award: $1980749
Description: ULTRA-LOW DOSE ADJUVANT FOR VACCINES AND MUCOSAL DEFENSE